<?xml version='1.0' encoding='UTF-8'?>
<uniprot>
<entry dataset="Swiss-Prot" created="1994-06-01" modified="2014-10-29" version="163">
<accession>Q04609</accession>
<accession>A4UU12</accession>
<accession>A9CB79</accession>
<accession>B7Z312</accession>
<accession>B7Z343</accession>
<accession>D3DQS5</accession>
<accession>E9PDX8</accession>
<accession>O43748</accession>
<accession>Q16305</accession>
<accession>Q541A4</accession>
<accession>Q8TAY3</accession>
<accession>Q9NP15</accession>
<accession>Q9NYE2</accession>
<accession>Q9P1P8</accession>
<name>FOLH1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Glutamate carboxypeptidase 2</fullName>
<ecNumber>3.4.17.21</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cell growth-inhibiting gene 27 protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Folate hydrolase 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Folylpoly-gamma-glutamate carboxypeptidase</fullName>
<shortName>FGCP</shortName>
</alternativeName>
<alternativeName>
<fullName>Glutamate carboxypeptidase II</fullName>
<shortName>GCPII</shortName>
</alternativeName>
<alternativeName>
<fullName>Membrane glutamate carboxypeptidase</fullName>
<shortName>mGCP</shortName>
</alternativeName>
<alternativeName>
<fullName>N-acetylated-alpha-linked acidic dipeptidase I</fullName>
<shortName>NAALADase I</shortName>
</alternativeName>
<alternativeName>
<fullName>Prostate-specific membrane antigen</fullName>
<shortName>PSM</shortName>
<shortName>PSMA</shortName>
</alternativeName>
<alternativeName>
<fullName>Pteroylpoly-gamma-glutamate carboxypeptidase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">FOLH1</name>
<name type="synonym">FOLH</name>
<name type="synonym">NAALAD1</name>
<name type="synonym">PSM</name>
<name type="synonym">PSMA</name>
<name type="ORF">GIG27</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Cancer Res." volume="53" first="227" last="230">
<title>Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.</title>
<authorList>
<person name="Israeli R.S."/>
<person name="Powell C.T."/>
<person name="Fair W.R."/>
<person name="Heston W.D.W."/>
</authorList>
<dbReference type="PubMed" id="8417812"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSMA-1)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<source>
<tissue>Prostatic carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Cancer Res." volume="55" first="1441" last="1443">
<title>Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression.</title>
<authorList>
<person name="Su S.L."/>
<person name="Huang I.-P."/>
<person name="Fair W.R."/>
<person name="Powell C.T."/>
<person name="Heston W.D.W."/>
</authorList>
<dbReference type="PubMed" id="7882349"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSMA')</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Biochim. Biophys. Acta" volume="1443" first="113" last="127">
<title>Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene.</title>
<authorList>
<person name="O'Keefe D.S."/>
<person name="Su S.L."/>
<person name="Bacich D.J."/>
<person name="Horiguchi Y."/>
<person name="Luo Y."/>
<person name="Powell C.T."/>
<person name="Zandvliet D."/>
<person name="Russell P.J."/>
<person name="Molloy P.L."/>
<person name="Nowak N.J."/>
<person name="Shows T.B."/>
<person name="Mullins C."/>
<person name="Vonder Haar R.A."/>
<person name="Fair W.R."/>
<person name="Heston W.D.W."/>
</authorList>
<dbReference type="PubMed" id="9838072"/>
<dbReference type="DOI" id="10.1016/S0167-4781(98)00200-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM PSMA-1)</scope>
<scope>VARIANT HIS-75</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1998" name="J. Pharmacol. Exp. Ther." volume="286" first="1020" last="1025">
<title>Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase).</title>
<authorList>
<person name="Luthi-Carter R."/>
<person name="Barczak A.K."/>
<person name="Speno H."/>
<person name="Coyle J.T."/>
</authorList>
<dbReference type="PubMed" id="9694964"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSMA-1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="8470" last="8483">
<title>Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity.</title>
<authorList>
<person name="Pangalos M.N."/>
<person name="Neefs J.-M."/>
<person name="Somers M."/>
<person name="Verhasselt P."/>
<person name="Bekkers M."/>
<person name="van der Helm L."/>
<person name="Fraiponts E."/>
<person name="Ashton D."/>
<person name="Gordon R.D."/>
</authorList>
<dbReference type="PubMed" id="10085079"/>
<dbReference type="DOI" id="10.1074/jbc.274.13.8470"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSMA-1)</scope>
<scope>CHARACTERIZATION</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Hum. Mol. Genet." volume="9" first="2837" last="2844">
<title>Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia.</title>
<authorList>
<person name="Devlin A.M."/>
<person name="Ling E.-H."/>
<person name="Peerson J.M."/>
<person name="Fernando S."/>
<person name="Clarke R."/>
<person name="Smith A.D."/>
<person name="Halsted C.H."/>
</authorList>
<dbReference type="PubMed" id="11092759"/>
<dbReference type="DOI" id="10.1093/hmg/9.19.2837"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSMA-1)</scope>
<scope>VARIANT TYR-475</scope>
<source>
<tissue>Jejunum</tissue>
<tissue>Small intestine</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Mian Yi Xue Za Zhi" volume="17" first="328" last="330">
<title>Cloning and sequencing of Chinese prostate-specific membrane antigen.</title>
<authorList>
<person name="Ye C.Z."/>
<person name="Zhang F.L."/>
<person name="Zhang Y.K."/>
<person name="Chen C.Q."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSMA-1)</scope>
<source>
<tissue>Prostatic carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="Prostate" volume="67" first="1791" last="1800">
<title>High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.</title>
<authorList>
<person name="Cao K.Y."/>
<person name="Mao X.P."/>
<person name="Wang D.H."/>
<person name="Xu L."/>
<person name="Yuan G.Q."/>
<person name="Dai S.Q."/>
<person name="Zheng B.J."/>
<person name="Qiu S.P."/>
</authorList>
<dbReference type="PubMed" id="17929272"/>
<dbReference type="DOI" id="10.1002/pros.20664"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSMA-9)</scope>
</reference>
<reference key="9">
<citation type="submission" date="1998-11" db="EMBL/GenBank/DDBJ databases">
<title>Identification of three novel splice variants of prostate-specific membrane antigen.</title>
<authorList>
<person name="Peace D.J."/>
<person name="Zhang Y."/>
<person name="Holt G."/>
<person name="Ferrer K.T."/>
<person name="Heller M."/>
<person name="Sosman J.A."/>
<person name="Xue B.H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="submission" date="2005-06" db="EMBL/GenBank/DDBJ databases">
<title>Identification of a cell growth-inhibiting gene.</title>
<authorList>
<person name="Kim J.W."/>
<person name="Kim H.K."/>
<person name="Shin S.M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSMA-8)</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS PSMA-1; PSMA-7 AND 10)</scope>
<source>
<tissue>Amygdala</tissue>
<tissue>Corpus callosum</tissue>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Nature" volume="440" first="497" last="500">
<title>Human chromosome 11 DNA sequence and analysis including novel gene identification.</title>
<authorList>
<person name="Taylor T.D."/>
<person name="Noguchi H."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Kuroki Y."/>
<person name="Dewar K."/>
<person name="Lloyd C."/>
<person name="Itoh T."/>
<person name="Takeda T."/>
<person name="Kim D.-W."/>
<person name="She X."/>
<person name="Barlow K.F."/>
<person name="Bloom T."/>
<person name="Bruford E."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Eichler E."/>
<person name="FitzGerald M.G."/>
<person name="Jaffe D.B."/>
<person name="LaButti K."/>
<person name="Nicol R."/>
<person name="Park H.-S."/>
<person name="Seaman C."/>
<person name="Sougnez C."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Zody M.C."/>
<person name="Birren B.W."/>
<person name="Nusbaum C."/>
<person name="Fujiyama A."/>
<person name="Hattori M."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Sakaki Y."/>
</authorList>
<dbReference type="PubMed" id="16554811"/>
<dbReference type="DOI" id="10.1038/nature04632"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="13">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PSMA-8)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="1997" name="J. Neurochem." volume="69" first="2270" last="2277">
<title>Molecular cloning of a peptidase against N-acetylaspartylglutamate from a rat hippocampal cDNA library.</title>
<authorList>
<person name="Bzdega T."/>
<person name="Turi T."/>
<person name="Wroblewska B."/>
<person name="She D."/>
<person name="Chung H.S."/>
<person name="Kim H."/>
<person name="Neale J.H."/>
</authorList>
<dbReference type="PubMed" id="9375657"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSMA-3)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="16">
<citation type="submission" date="2000-04" db="EMBL/GenBank/DDBJ databases">
<title>Alternative splicing of the prostate-specific membrane antigen.</title>
<authorList>
<person name="Lupold S.E."/>
<person name="Criley S.C."/>
<person name="Coffey D.S."/>
</authorList>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSMA-4)</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1998" name="Cancer Res." volume="58" first="4787" last="4789">
<title>Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line.</title>
<authorList>
<person name="Grauer L.S."/>
<person name="Lawler K.D."/>
<person name="Marignac J.L."/>
<person name="Kumar A."/>
<person name="Goel A.S."/>
<person name="Wolfert R.L."/>
</authorList>
<dbReference type="PubMed" id="9809977"/>
</citation>
<scope>PROTEIN SEQUENCE OF 60-74</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Prostatic carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="1998" name="Abstr. - Soc. Neurosci." volume="24" first="579" last="579">
<title>Molecular cloning of alternatively spliced variants of the peptidase against N-acetylaspartylglutamate (NAAG) from human and rat nervous systems.</title>
<authorList>
<person name="Bzdega T."/>
<person name="She D."/>
<person name="Turi T."/>
<person name="Wroblewska B."/>
<person name="Neale J.H."/>
</authorList>
</citation>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1998" name="Brain Res." volume="795" first="341" last="348">
<title>Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II.</title>
<authorList>
<person name="Luthi-Carter R."/>
<person name="Barczak A.K."/>
<person name="Speno H.D."/>
<person name="Coyle J.T."/>
</authorList>
<dbReference type="PubMed" id="9622670"/>
<dbReference type="DOI" id="10.1016/S0006-8993(98)00244-3"/>
</citation>
<scope>CHARACTERIZATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1997" name="Biochim. Biophys. Acta" volume="1339" first="247" last="252">
<title>Structure of membrane glutamate carboxypeptidase.</title>
<authorList>
<person name="Rawlings N.D."/>
<person name="Barrett A.J."/>
</authorList>
<dbReference type="PubMed" id="9187245"/>
<dbReference type="DOI" id="10.1016/S0167-4838(97)00008-3"/>
</citation>
<scope>DOMAIN STRUCTURE</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1999" name="Mol. Pharmacol." volume="55" first="179" last="185">
<title>Site-directed mutagenesis of predicted active site residues in glutamate carboxypeptidase II.</title>
<authorList>
<person name="Speno H.S."/>
<person name="Luthi-Carter R."/>
<person name="Macias W.L."/>
<person name="Valentine S.L."/>
<person name="Joshi A.R.T."/>
<person name="Coyle J.T."/>
</authorList>
<dbReference type="PubMed" id="9882712"/>
</citation>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="Nat. Biotechnol." volume="21" first="660" last="666">
<title>Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.</title>
<authorList>
<person name="Zhang H."/>
<person name="Li X.-J."/>
<person name="Martin D.B."/>
<person name="Aebersold R."/>
</authorList>
<dbReference type="PubMed" id="12754519"/>
<dbReference type="DOI" id="10.1038/nbt827"/>
</citation>
<scope>GLYCOSYLATION AT ASN-76; ASN-336; ASN-459; ASN-476 AND ASN-638</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="1627" last="1635">
<title>Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity.</title>
<authorList>
<person name="Barinka C."/>
<person name="Sacha P."/>
<person name="Sklenar J."/>
<person name="Man P."/>
<person name="Bezouska K."/>
<person name="Slusher B.S."/>
<person name="Konvalinka J."/>
</authorList>
<dbReference type="PubMed" id="15152093"/>
<dbReference type="DOI" id="10.1110/ps.04622104"/>
</citation>
<scope>GLYCOSYLATION AT ASN-51; ASN-76; ASN-121; ASN-140; ASN-153; ASN-195; ASN-336; ASN-459; ASN-476 AND ASN-638</scope>
<scope>MUTAGENESIS OF ASN-51; ASN-76; ASN-121; ASN-140; ASN-153; ASN-195; ASN-336; ASN-459; ASN-476; ASN-638 AND THR-640</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Prostate" volume="58" first="200" last="210">
<title>Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene.</title>
<authorList>
<person name="O'Keefe D.S."/>
<person name="Bacich D.J."/>
<person name="Heston W.D.W."/>
</authorList>
<dbReference type="PubMed" id="14716746"/>
<dbReference type="DOI" id="10.1002/pros.10319"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="World J. Surg." volume="30" first="628" last="636">
<title>Expression of prostate-specific membrane antigen in normal and malignant human tissues.</title>
<authorList>
<person name="Kinoshita Y."/>
<person name="Kuratsukuri K."/>
<person name="Landas S."/>
<person name="Imaida K."/>
<person name="Rovito P.M. Jr."/>
<person name="Wang C.Y."/>
<person name="Haas G.P."/>
</authorList>
<dbReference type="PubMed" id="16555021"/>
<dbReference type="DOI" id="10.1007/s00268-005-0544-5"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="Neuroscience" volume="144" first="1361" last="1372">
<title>Expression of glutamate carboxypeptidase II in human brain.</title>
<authorList>
<person name="Sacha P."/>
<person name="Zamecnik J."/>
<person name="Barinka C."/>
<person name="Hlouchova K."/>
<person name="Vicha A."/>
<person name="Mlcochova P."/>
<person name="Hilgert I."/>
<person name="Eckschlager T."/>
<person name="Konvalinka J."/>
</authorList>
<dbReference type="PubMed" id="17150306"/>
<dbReference type="DOI" id="10.1016/j.neuroscience.2006.10.022"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="1375" last="1384">
<title>Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.</title>
<authorList>
<person name="Mesters J.R."/>
<person name="Barinka C."/>
<person name="Li W."/>
<person name="Tsukamoto T."/>
<person name="Majer P."/>
<person name="Slusher B.S."/>
<person name="Konvalinka J."/>
<person name="Hilgenfeld R."/>
</authorList>
<dbReference type="PubMed" id="16467855"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600969"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 44-750 IN COMPLEXES WITH GLUTAMATE; INHIBITORS; CALCIUM AND ZINC IONS</scope>
<scope>COFACTOR</scope>
<scope>SUBUNIT</scope>
<scope>GLYCOSYLATION AT ASN-76; ASN-121; ASN-140; ASN-195; ASN-459; ASN-476 AND ASN-638</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="Acta Crystallogr. D" volume="63" first="508" last="513">
<title>Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA.</title>
<authorList>
<person name="Mesters J.R."/>
<person name="Henning K."/>
<person name="Hilgenfeld R."/>
</authorList>
<dbReference type="PubMed" id="17372356"/>
<dbReference type="DOI" id="10.1107/S090744490700902X"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.19 ANGSTROMS) OF 44-750 IN COMPLEXES WITH THE INHIBITORS QUISQUALATE AND 2-PMPA; CALCIUM AND ZINC IONS</scope>
<scope>GLYCOSYLATION AT ASN-76; ASN-121; ASN-140; ASN-195; ASN-459; ASN-476 AND ASN-638</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="J. Med. Chem." volume="50" first="3267" last="3273">
<title>Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II.</title>
<authorList>
<person name="Barinka C."/>
<person name="Rovenska M."/>
<person name="Mlcochova P."/>
<person name="Hlouchova K."/>
<person name="Plechanovova A."/>
<person name="Majer P."/>
<person name="Tsukamoto T."/>
<person name="Slusher B.S."/>
<person name="Konvalinka J."/>
<person name="Lubkowski J."/>
</authorList>
<dbReference type="PubMed" id="17567119"/>
<dbReference type="DOI" id="10.1021/jm070133w"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.62 ANGSTROMS) OF 44-750 IN COMPLEXES WITH SUBSTRATE ANALOGS; CALCIUM AND ZINC IONS</scope>
<scope>ENZYME REGULATION</scope>
<scope>GLYCOSYLATION AT ASN-76; ASN-121; ASN-140 ASN-195; ASN-459; ASN-476 AND ASN-638</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="J. Med. Chem." volume="51" first="7737" last="7743">
<title>Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization.</title>
<authorList>
<person name="Barinka C."/>
<person name="Byun Y."/>
<person name="Dusich C.L."/>
<person name="Banerjee S.R."/>
<person name="Chen Y."/>
<person name="Castanares M."/>
<person name="Kozikowski A.P."/>
<person name="Mease R.C."/>
<person name="Pomper M.G."/>
<person name="Lubkowski J."/>
</authorList>
<dbReference type="PubMed" id="19053759"/>
<dbReference type="DOI" id="10.1021/jm800765e"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS) OF 44-750 IN COMPLEXES WITH UREA-BASED INHIBITORS; CALCIUM AND ZINC IONS</scope>
<scope>GLYCOSYLATION AT ASN-76; ASN-121; ASN-140; ASN-195; ASN-459; ASN-476 AND ASN-638</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="J. Mol. Biol." volume="376" first="1438" last="1450">
<title>Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.</title>
<authorList>
<person name="Barinka C."/>
<person name="Hlouchova K."/>
<person name="Rovenska M."/>
<person name="Majer P."/>
<person name="Dauter M."/>
<person name="Hin N."/>
<person name="Ko Y.-S."/>
<person name="Tsukamoto T."/>
<person name="Slusher B.S."/>
<person name="Konvalinka J."/>
<person name="Lubkowski J."/>
</authorList>
<dbReference type="PubMed" id="18234225"/>
<dbReference type="DOI" id="10.1016/j.jmb.2007.12.066"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 44-750 IN COMPLEXES WITH SUBSTRATE ANALOGS; CALCIUM AND ZINC IONS</scope>
<scope>GLYCOSYLATION AT ASN-76; ASN-121; ASN-140; ASN-195; ASN-459; ASN-476 AND ASN-638</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Biochemistry" volume="48" first="4126" last="4138">
<title>Reaction mechanism of glutamate carboxypeptidase II revealed by mutagenesis, X-ray crystallography, and computational methods.</title>
<authorList>
<person name="Klusak V."/>
<person name="Barinka C."/>
<person name="Plechanovova A."/>
<person name="Mlcochova P."/>
<person name="Konvalinka J."/>
<person name="Rulisek L."/>
<person name="Lubkowski J."/>
</authorList>
<dbReference type="PubMed" id="19301871"/>
<dbReference type="DOI" id="10.1021/bi900220s"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 44-750 IN COMPLEX WITH SUBSTRATE; CALCIUM AND ZINC IONS</scope>
<scope>GLYCOSYLATION AT ASN-76; ASN-121; ASN-140; ASN-195; ASN-459; ASN-476 AND ASN-638</scope>
<scope>MUTAGENESIS OF GLU-424</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] THR-23</scope>
</reference>
<comment type="function">
<text>Has both folate hydrolase and N-acetylated-alpha-linked-acidic dipeptidase (NAALADase) activity. Has a preference for tri-alpha-glutamate peptides. In the intestine, required for the uptake of folate. In the brain, modulates excitatory neurotransmission through the hydrolysis of the neuropeptide, N-aceylaspartylglutamate (NAAG), thereby releasing glutamate. Isoform PSM-4 and isoform PSM-5 would appear to be physiologically irrelevant. Involved in prostate tumor progression.</text>
</comment>
<comment type="function">
<text>Also exhibits a dipeptidyl-peptidase IV type activity. In vitro, cleaves Gly-Pro-AMC.</text>
</comment>
<comment type="catalytic activity">
<text>Release of an unsubstituted, C-terminal glutamyl residue, typically from Ac-Asp-Glu or folylpoly-gamma-glutamates.</text>
</comment>
<comment type="cofactor">
<text evidence="6">Binds 2 zinc ions per subunit. Required for NAALADase activity.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="11">The NAALADase activity is inhibited by beta-NAAG, quisqualic acid, 2-(phosphonomethyl) pentanedioic acid (PMPA) and EDTA. Activated by cobalt.</text>
</comment>
<comment type="biophysicochemical properties">
<phDependence>Stable at pH greater than 6.5.</phDependence>
</comment>
<comment type="subunit">
<text evidence="6 14">Homodimer.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="17">Cell membrane</location>
<topology evidence="17">Single-pass type II membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform PSMA'</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q04609-1</id>
<name>PSMA-1</name>
<sequence type="displayed"/>
<note>No experimental confirmation available.</note>
</isoform>
<isoform>
<id>Q04609-3</id>
<name>PSMA-3</name>
<sequence type="described" ref="VSP_040242 VSP_040245"/>
<note>No experimental confirmation available. Incomplete sequence.</note>
</isoform>
<isoform>
<id>Q04609-4</id>
<name>PSMA-4</name>
<sequence type="described" ref="VSP_040241 VSP_040243 VSP_040244"/>
<note>No experimental confirmation available. Incomplete sequence.</note>
</isoform>
<isoform>
<id>Q04609-6</id>
<name>PSMA'</name>
<sequence type="described" ref="VSP_005336"/>
</isoform>
<isoform>
<id>Q04609-7</id>
<name>PSMA-7</name>
<sequence type="described" ref="VSP_038058"/>
</isoform>
<isoform>
<id>Q04609-8</id>
<name>PSMA-8</name>
<sequence type="described" ref="VSP_038059"/>
</isoform>
<isoform>
<id>Q04609-9</id>
<name>PSMA-9</name>
<name>PSM-E</name>
<sequence type="described" ref="VSP_038058 VSP_038059"/>
</isoform>
<isoform>
<id>Q04609-10</id>
<name>10</name>
<sequence type="described" ref="VSP_044287"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="4 7 9 16">Highly expressed in prostate epithelium. Detected in urinary bladder, kidney, testis, ovary, fallopian tube, breast, adrenal gland, liver, esophagus, stomach, small intestine, colon and brain (at protein level). Detected in the small intestine, brain, kidney, liver, spleen, colon, trachea, spinal cord and the capillary endothelium of a variety of tumors. Expressed specifically in jejunum brush border membranes. In the brain, highly expressed in the ventral striatum and brain stem. Also expressed in fetal liver and kidney. Isoform PSMA' is the most abundant form in normal prostate. Isoform PSMA-1 is the most abundant form in primary prostate tumors. Isoform PSMA-2 is also found in normal prostate as well as in brain and liver. Isoform PSMA-9 is specifically expressed in prostate cancer.</text>
</comment>
<comment type="induction">
<text>In the prostate, up-regulated in response to androgen deprivation.</text>
</comment>
<comment type="domain">
<text evidence="15">The NAALADase activity is found in the central region, the dipeptidyl peptidase IV type activity in the C-terminal.</text>
</comment>
<comment type="PTM">
<text>The first two amino acids at the N-terminus of isoform PSMA' appear to be cleaved by limited proteolysis.</text>
</comment>
<comment type="PTM">
<text>The N-terminus is blocked.</text>
</comment>
<comment type="polymorphism">
<text>Genetic variation in FOLH1 may be associated with low folate levels and consequent hyperhomocysteinemia. This condition can result in increased risk of cardiovascular disease, neural tube defects, and cognitive deficits.</text>
</comment>
<comment type="miscellaneous">
<text>PSMA is used as a diagnostic and prognostic indicator of prostate cancer, and as a possible marker for various neurological disorders such as schizophrenia, Alzheimer disease and Huntington disease.</text>
</comment>
<comment type="similarity">
<text evidence="25">Belongs to the peptidase M28 family. M28B subfamily.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAF31167" version="1"/>
</conflict>
</comment>
<dbReference type="EC" id="3.4.17.21"/>
<dbReference type="EMBL" id="M99487">
<property type="protein sequence ID" value="AAA60209.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S76978">
<property type="protein sequence ID" value="AAB33750.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF007544">
<property type="protein sequence ID" value="AAC83972.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF176574">
<property type="protein sequence ID" value="AAD51121.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF488811">
<property type="protein sequence ID" value="ABO93402.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY101595">
<property type="protein sequence ID" value="AAM34479.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF107214">
<property type="protein sequence ID" value="AAF31167.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ088979">
<property type="protein sequence ID" value="AAZ66619.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312366">
<property type="protein sequence ID" value="BAG35284.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK295368">
<property type="protein sequence ID" value="BAH12048.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK295470">
<property type="protein sequence ID" value="BAH12079.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC110742">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC118273">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471064">
<property type="protein sequence ID" value="EAW67858.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471064">
<property type="protein sequence ID" value="EAW67861.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471064">
<property type="protein sequence ID" value="EAW67857.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471064">
<property type="protein sequence ID" value="EAW67859.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC025672">
<property type="protein sequence ID" value="AAH25672.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF254358">
<property type="protein sequence ID" value="AAF71358.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF254357">
<property type="protein sequence ID" value="AAF71357.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31493.1">
<molecule id="Q04609-8"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53626.1">
<molecule id="Q04609-10"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53627.1">
<molecule id="Q04609-9"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53628.1">
<molecule id="Q04609-7"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7946.1">
<molecule id="Q04609-1"/>
</dbReference>
<dbReference type="PIR" id="A56881">
<property type="entry name" value="A56881"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001014986.1">
<molecule id="Q04609-8"/>
<property type="nucleotide sequence ID" value="NM_001014986.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180400.1">
<molecule id="Q04609-7"/>
<property type="nucleotide sequence ID" value="NM_001193471.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180401.1">
<molecule id="Q04609-9"/>
<property type="nucleotide sequence ID" value="NM_001193472.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180402.1">
<molecule id="Q04609-10"/>
<property type="nucleotide sequence ID" value="NM_001193473.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004467.1">
<molecule id="Q04609-1"/>
<property type="nucleotide sequence ID" value="NM_004476.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.654487"/>
<dbReference type="PDB" id="1Z8L">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B/C/D=56-750"/>
</dbReference>
<dbReference type="PDB" id="2C6C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2C6G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2C6P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2CIJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2JBJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2JBK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.99"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2OOT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.64"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2OR4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.62"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2PVV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.11"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2PVW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.71"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2XEF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.59"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2XEG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.59"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2XEI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.69"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="2XEJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.78"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3BHX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3BI0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.67"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3BI1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3BXM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.71"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3D7D">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.69"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3D7F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.54"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3D7G">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3D7H">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3IWW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3RBU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3SJE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3SJF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3SJG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="3SJX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4JYW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.73"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4JZ0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4MCP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4MCQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4MCR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4MCS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4NGM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.84"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4NGN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.64"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4NGP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.63"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4NGQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.08"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4NGR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4NGS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.68"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4NGT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4OC0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4OC1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4OC2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4OC3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4OC4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDB" id="4OC5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=44-750"/>
</dbReference>
<dbReference type="PDBsum" id="1Z8L"/>
<dbReference type="PDBsum" id="2C6C"/>
<dbReference type="PDBsum" id="2C6G"/>
<dbReference type="PDBsum" id="2C6P"/>
<dbReference type="PDBsum" id="2CIJ"/>
<dbReference type="PDBsum" id="2JBJ"/>
<dbReference type="PDBsum" id="2JBK"/>
<dbReference type="PDBsum" id="2OOT"/>
<dbReference type="PDBsum" id="2OR4"/>
<dbReference type="PDBsum" id="2PVV"/>
<dbReference type="PDBsum" id="2PVW"/>
<dbReference type="PDBsum" id="2XEF"/>
<dbReference type="PDBsum" id="2XEG"/>
<dbReference type="PDBsum" id="2XEI"/>
<dbReference type="PDBsum" id="2XEJ"/>
<dbReference type="PDBsum" id="3BHX"/>
<dbReference type="PDBsum" id="3BI0"/>
<dbReference type="PDBsum" id="3BI1"/>
<dbReference type="PDBsum" id="3BXM"/>
<dbReference type="PDBsum" id="3D7D"/>
<dbReference type="PDBsum" id="3D7F"/>
<dbReference type="PDBsum" id="3D7G"/>
<dbReference type="PDBsum" id="3D7H"/>
<dbReference type="PDBsum" id="3IWW"/>
<dbReference type="PDBsum" id="3RBU"/>
<dbReference type="PDBsum" id="3SJE"/>
<dbReference type="PDBsum" id="3SJF"/>
<dbReference type="PDBsum" id="3SJG"/>
<dbReference type="PDBsum" id="3SJX"/>
<dbReference type="PDBsum" id="4JYW"/>
<dbReference type="PDBsum" id="4JZ0"/>
<dbReference type="PDBsum" id="4MCP"/>
<dbReference type="PDBsum" id="4MCQ"/>
<dbReference type="PDBsum" id="4MCR"/>
<dbReference type="PDBsum" id="4MCS"/>
<dbReference type="PDBsum" id="4NGM"/>
<dbReference type="PDBsum" id="4NGN"/>
<dbReference type="PDBsum" id="4NGP"/>
<dbReference type="PDBsum" id="4NGQ"/>
<dbReference type="PDBsum" id="4NGR"/>
<dbReference type="PDBsum" id="4NGS"/>
<dbReference type="PDBsum" id="4NGT"/>
<dbReference type="PDBsum" id="4OC0"/>
<dbReference type="PDBsum" id="4OC1"/>
<dbReference type="PDBsum" id="4OC2"/>
<dbReference type="PDBsum" id="4OC3"/>
<dbReference type="PDBsum" id="4OC4"/>
<dbReference type="PDBsum" id="4OC5"/>
<dbReference type="ProteinModelPortal" id="Q04609"/>
<dbReference type="SMR" id="Q04609">
<property type="residue range" value="55-750"/>
</dbReference>
<dbReference type="BioGrid" id="108630">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="IntAct" id="Q04609">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="MINT" id="MINT-3025010"/>
<dbReference type="BindingDB" id="Q04609"/>
<dbReference type="ChEMBL" id="CHEMBL1892"/>
<dbReference type="DrugBank" id="DB00089">
<property type="generic name" value="Capromab"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1606"/>
<dbReference type="MEROPS" id="M28.010"/>
<dbReference type="PhosphoSite" id="Q04609"/>
<dbReference type="DMDM" id="548615"/>
<dbReference type="MaxQB" id="Q04609"/>
<dbReference type="PaxDb" id="Q04609"/>
<dbReference type="PRIDE" id="Q04609"/>
<dbReference type="DNASU" id="2346"/>
<dbReference type="Ensembl" id="ENST00000256999">
<molecule id="Q04609-1"/>
<property type="protein sequence ID" value="ENSP00000256999"/>
<property type="gene ID" value="ENSG00000086205"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000340334">
<molecule id="Q04609-7"/>
<property type="protein sequence ID" value="ENSP00000344131"/>
<property type="gene ID" value="ENSG00000086205"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000343844">
<molecule id="Q04609-10"/>
<property type="protein sequence ID" value="ENSP00000344086"/>
<property type="gene ID" value="ENSG00000086205"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000356696">
<molecule id="Q04609-8"/>
<property type="protein sequence ID" value="ENSP00000349129"/>
<property type="gene ID" value="ENSG00000086205"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000533034">
<molecule id="Q04609-9"/>
<property type="protein sequence ID" value="ENSP00000431463"/>
<property type="gene ID" value="ENSG00000086205"/>
</dbReference>
<dbReference type="GeneID" id="2346"/>
<dbReference type="KEGG" id="hsa:2346"/>
<dbReference type="UCSC" id="uc001ngx.3">
<molecule id="Q04609-3"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc001ngy.3">
<molecule id="Q04609-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc001ngz.3">
<molecule id="Q04609-8"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc009yly.3">
<molecule id="Q04609-7"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc009ylz.3">
<molecule id="Q04609-9"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2346"/>
<dbReference type="GeneCards" id="GC11M049168"/>
<dbReference type="H-InvDB" id="HIX0129475"/>
<dbReference type="HGNC" id="HGNC:3788">
<property type="gene designation" value="FOLH1"/>
</dbReference>
<dbReference type="HPA" id="CAB001451"/>
<dbReference type="HPA" id="HPA010593"/>
<dbReference type="MIM" id="600934">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q04609"/>
<dbReference type="PharmGKB" id="PA28205"/>
<dbReference type="eggNOG" id="NOG74799"/>
<dbReference type="GeneTree" id="ENSGT00550000074421"/>
<dbReference type="HOVERGEN" id="HBG051639"/>
<dbReference type="InParanoid" id="Q04609"/>
<dbReference type="KO" id="K14592"/>
<dbReference type="OMA" id="MWNPLHE"/>
<dbReference type="OrthoDB" id="EOG7QK0BC"/>
<dbReference type="PhylomeDB" id="Q04609"/>
<dbReference type="TreeFam" id="TF312981"/>
<dbReference type="EvolutionaryTrace" id="Q04609"/>
<dbReference type="GeneWiki" id="Glutamate_carboxypeptidase_II"/>
<dbReference type="GenomeRNAi" id="2346"/>
<dbReference type="NextBio" id="9513"/>
<dbReference type="PRO" id="PR:Q04609"/>
<dbReference type="Bgee" id="Q04609"/>
<dbReference type="CleanEx" id="HS_FOLH1"/>
<dbReference type="ExpressionAtlas" id="Q04609">
<property type="expression patterns" value="baseline"/>
</dbReference>
<dbReference type="Genevestigator" id="Q04609"/>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular vesicular exosome"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="NAS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004180">
<property type="term" value="F:carboxypeptidase activity"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016805">
<property type="term" value="F:dipeptidase activity"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008237">
<property type="term" value="F:metallopeptidase activity"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008233">
<property type="term" value="F:peptidase activity"/>
<property type="evidence" value="NAS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006760">
<property type="term" value="P:folic acid-containing compound metabolic process"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006508">
<property type="term" value="P:proteolysis"/>
<property type="evidence" value="NAS:UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.930.40">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007484">
<property type="entry name" value="Peptidase_M28"/>
</dbReference>
<dbReference type="InterPro" id="IPR003137">
<property type="entry name" value="Protease-assoc_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR007365">
<property type="entry name" value="TFR-like_dimer_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF02225">
<property type="entry name" value="PA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04389">
<property type="entry name" value="Peptidase_M28"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04253">
<property type="entry name" value="TFR_dimer"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47672">
<property type="entry name" value="SSF47672"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0121">Carboxypeptidase</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0224">Dipeptidase</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0482">Metalloprotease</keyword>
<keyword id="KW-0511">Multifunctional enzyme</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0645">Protease</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Glutamate carboxypeptidase 2" id="PRO_0000174117">
<location>
<begin position="1"/>
<end position="750"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="25">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type II membrane protein" evidence="25">
<location>
<begin position="20"/>
<end position="43"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="25">
<location>
<begin position="44"/>
<end position="750"/>
</location>
</feature>
<feature type="region of interest" description="NAALADase">
<location>
<begin position="274"/>
<end position="587"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding">
<location>
<begin position="534"/>
<end position="536"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding">
<location>
<begin position="699"/>
<end position="700"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="146"/>
<end position="149"/>
</location>
</feature>
<feature type="active site" description="For NAALADase activity">
<location>
<position position="424"/>
</location>
</feature>
<feature type="active site" description="Charge relay system" evidence="1">
<location>
<position position="628"/>
</location>
</feature>
<feature type="active site" description="Charge relay system" evidence="1">
<location>
<position position="666"/>
</location>
</feature>
<feature type="active site" description="Charge relay system" evidence="1">
<location>
<position position="689"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="14">
<location>
<position position="269"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen" evidence="14">
<location>
<position position="272"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="377"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="387"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="387"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="425"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="14">
<location>
<position position="433"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="14">
<location>
<position position="436"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="453"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="553"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="14">
<location>
<position position="210"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="14">
<location>
<position position="257"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="14">
<location>
<position position="519"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="14">
<location>
<position position="552"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="5">
<location>
<position position="51"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="3 5 6 10 11 12 13 14">
<location>
<position position="76"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="5 6 10 11 12 13 14">
<location>
<position position="121"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="5 6 10 11 12 13 14">
<location>
<position position="140"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="5">
<location>
<position position="153"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="5 6 10 11 12 13 14">
<location>
<position position="195"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="3 5">
<location>
<position position="336"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="3 5 6 10 11 12 13 14">
<location>
<position position="459"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="3 5 6 10 11 12 13 14">
<location>
<position position="476"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="3 5 6 10 11 12 13 14">
<location>
<position position="638"/>
</location>
</feature>
<feature type="splice variant" description="In isoform PSMA-3." id="VSP_040242" evidence="25">
<location>
<begin position="1"/>
<end position="585"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 10." id="VSP_044287" evidence="20">
<location>
<begin position="1"/>
<end position="308"/>
</location>
</feature>
<feature type="splice variant" description="In isoform PSMA-4." id="VSP_040241" evidence="25">
<location>
<begin position="1"/>
<end position="159"/>
</location>
</feature>
<feature type="splice variant" description="In isoform PSMA'." id="VSP_005336" evidence="23">
<location>
<begin position="1"/>
<end position="57"/>
</location>
</feature>
<feature type="splice variant" description="In isoform PSMA-7 and isoform PSMA-9." id="VSP_038058" evidence="20 22">
<original>MWNLLHETDSAVATARRPRWLCAGALVLAGGFFLLGFLF</original>
<variation>MTAGSSYPLFLAAYACTGCLAERL</variation>
<location>
<begin position="1"/>
<end position="39"/>
</location>
</feature>
<feature type="splice variant" description="In isoform PSMA-4." id="VSP_040243" evidence="25">
<original>VKNAQLAGAKGVILYSDPADYFAPGVKSYP</original>
<variation>NMLIGVELQRLLVFQVFLFIQLDTMMHRSS</variation>
<location>
<begin position="214"/>
<end position="243"/>
</location>
</feature>
<feature type="splice variant" description="In isoform PSMA-4." id="VSP_040244" evidence="25">
<location>
<begin position="244"/>
<end position="750"/>
</location>
</feature>
<feature type="splice variant" description="In isoform PSMA-3." id="VSP_040245" evidence="25">
<original>NPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA</original>
<variation>MSSMLQAATTSMQGSHSQEFMMLCLILKAKWTLPRPGEK</variation>
<location>
<begin position="657"/>
<end position="750"/>
</location>
</feature>
<feature type="splice variant" description="In isoform PSMA-8 and isoform PSMA-9." id="VSP_038059" evidence="21 22 24">
<original>NPIVLRMMNDQLMFLERAFIDPLGLPDRPFYR</original>
<variation>K</variation>
<location>
<begin position="657"/>
<end position="688"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation." id="VAR_036398" evidence="8">
<original>A</original>
<variation>T</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs202676." id="VAR_024592" evidence="18">
<original>Y</original>
<variation>H</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="sequence variant" description="Can be associated with lower folate and higher homocysteine levels; dbSNP:rs61886492." id="VAR_012736" evidence="2">
<original>H</original>
<variation>Y</variation>
<location>
<position position="475"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2988342." id="VAR_028882">
<original>V</original>
<variation>L</variation>
<location>
<position position="627"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation. Reduces enzyme activity." evidence="5">
<original>N</original>
<variation>A</variation>
<location>
<position position="51"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation. Reduces enzyme activity." evidence="5">
<original>N</original>
<variation>A</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation. Severely reduced enzyme activity." evidence="5">
<original>N</original>
<variation>A</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation. Severely reduced enzyme activity." evidence="5">
<original>N</original>
<variation>A</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation. Severely reduced enzyme activity." evidence="5">
<original>N</original>
<variation>A</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation. Severely reduced enzyme activity." evidence="5">
<original>N</original>
<variation>A</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation. Reduces enzyme activity." evidence="5">
<original>N</original>
<variation>A</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of activity." evidence="19">
<original>H</original>
<variation>A</variation>
<variation>G</variation>
<variation>Q</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of activity." evidence="19">
<original>D</original>
<variation>E</variation>
<variation>N</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of activity." evidence="19">
<original>D</original>
<variation>E</variation>
<variation>L</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on enzyme activity." evidence="19">
<original>D</original>
<variation>N</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on enzyme activity." evidence="19">
<original>P</original>
<variation>A</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of activity." evidence="14">
<original>E</original>
<variation>A</variation>
<location>
<position position="424"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces enzyme activity." evidence="14">
<original>E</original>
<variation>D</variation>
<location>
<position position="424"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces enzyme activity." evidence="14">
<original>E</original>
<variation>Q</variation>
<location>
<position position="424"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of activity." evidence="19">
<original>E</original>
<variation>Q</variation>
<variation>D</variation>
<location>
<position position="425"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of activity." evidence="19">
<original>D</original>
<variation>N</variation>
<variation>L</variation>
<location>
<position position="453"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces enzyme activity." evidence="19">
<original>D</original>
<variation>Q</variation>
<location>
<position position="453"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces enzyme activity." evidence="19">
<original>S</original>
<variation>A</variation>
<location>
<position position="454"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation. Reduces enzyme activity." evidence="5">
<original>N</original>
<variation>A</variation>
<location>
<position position="459"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation. Reduces enzyme activity." evidence="5">
<original>N</original>
<variation>A</variation>
<location>
<position position="476"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation. Abolishes enzyme activity." evidence="5">
<original>N</original>
<variation>A</variation>
<location>
<position position="638"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzyme activity." evidence="5">
<original>T</original>
<variation>A</variation>
<location>
<position position="640"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AAZ66619." ref="9" evidence="25">
<original>I</original>
<variation>V</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AA sequence." ref="1" evidence="25">
<original>R</original>
<variation>K</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; ABO93402." ref="8" evidence="25">
<original>I</original>
<variation>N</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="58"/>
<end position="64"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="67"/>
<end position="77"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="78"/>
<end position="80"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="87"/>
<end position="103"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="106"/>
<end position="119"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="122"/>
<end position="124"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="127"/>
<end position="131"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="137"/>
<end position="140"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="149"/>
<end position="151"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="174"/>
<end position="176"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="182"/>
<end position="190"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="200"/>
<end position="204"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="210"/>
<end position="219"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="223"/>
<end position="228"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="231"/>
<end position="234"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="244"/>
<end position="247"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="269"/>
<end position="272"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="283"/>
<end position="285"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="294"/>
<end position="297"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="299"/>
<end position="306"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="317"/>
<end position="319"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="322"/>
<end position="325"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="330"/>
<end position="333"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="335"/>
<end position="337"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="341"/>
<end position="346"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="349"/>
<end position="362"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="365"/>
<end position="377"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="381"/>
<end position="383"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="385"/>
<end position="388"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="389"/>
<end position="407"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="413"/>
<end position="423"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="424"/>
<end position="426"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="429"/>
<end position="445"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="446"/>
<end position="451"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="455"/>
<end position="457"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="459"/>
<end position="466"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="468"/>
<end position="470"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="471"/>
<end position="479"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="480"/>
<end position="482"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="486"/>
<end position="490"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="493"/>
<end position="500"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="504"/>
<end position="506"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="507"/>
<end position="510"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="517"/>
<end position="519"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="521"/>
<end position="526"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="531"/>
<end position="538"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="541"/>
<end position="543"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="545"/>
<end position="547"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="550"/>
<end position="553"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="559"/>
<end position="565"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="571"/>
<end position="589"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="597"/>
<end position="615"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="619"/>
<end position="624"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="630"/>
<end position="652"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="658"/>
<end position="673"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="684"/>
<end position="686"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="689"/>
<end position="695"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="698"/>
<end position="705"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="706"/>
<end position="712"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="715"/>
<end position="717"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="721"/>
<end position="744"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255"/>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11092759"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12754519"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14716746"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15152093"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16467855"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16555021"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17150306"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17372356"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17567119"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18234225"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19053759"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19301871"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9187245"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9375657"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9809977"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9838072"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9882712"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17929272"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7882349"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source ref="10"/>
</evidence>
<evidence key="25" type="ECO:0000305"/>
<sequence length="750" mass="84331" checksum="AD8C0A7DBF47901A" modified="1994-06-01" version="1">
MWNLLHETDSAVATARRPRWLCAGALVLAGGFFLLGFLFGWFIKSSNEATNITPKHNMKA
FLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYP
NKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYA
RTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVK
SYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYY
DAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIG
TLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFAS
WDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKE
LKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKN
WETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDY
AVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIV
LRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVD
PSKAWGEVKRQIYVAAFTVQAAAETLSEVA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>